Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine

European Journal of Pediatrics

Volumn 170, Issue 7, 2011, Pages 859-863

  Cua, Clifford L ^a   Rogers, Lynette K ^a   Chicoine, Louis G ^a   Augustine, Molly ^a   Jin, Yi ^a   Nash, Patricia L ^a   Nelin, Leif D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

ADMA; Down syndrome; Pulmonary hypertension

Indexed keywords

ARGININE; CITRULLINE; HEMOGLOBIN; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRITE; ORNITHINE;

AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HEART CATHETERIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFANT; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ARGININE; BIOLOGICAL MARKERS; DOWN SYNDROME; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; NITRATES; NITRITES;

EID: 79959702238     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-010-1361-x     Document Type: Article

References (31)

1. (2009) Proceedings of the 4th World Symposium on Pulmonary Hypertension, February 2008, Dana Point, California, USA. J Am Coll Cardiol 54:S1-117
2. Beyer J, Kolditz M, Ewert R, Rubens C, Opitz C, Schellong S, Hoeffken G, Halank M (2008) L-arginine plasma levels and severity of idiopathic pulmonary arterial hypertension. Vasa 37:61-67 (Pubitemid 351341141)
3. Boger RH, Mugge A, Bode-Boger SM, Heinzel D, Hoper MM, Frolich JC(1996)Differential systemic and pulmonary hemodynamic effects of L-arginine in patients with coronary artery disease or primary pulmonary hypertension. Int J Clin Pharmacol Ther 34:323-328 (Pubitemid 26270998)
4. Clapp S, Perry BL, Farooki ZQ, Jackson WL, Karpawich PP, Hakimi M, Arciniegas E, Green EW, Pinsky WW (1990) Down's syndrome, complete atrioventricular canal, and pulmonary vascular obstructive disease. J Thorac Cardiovasc Surg 100:115-121 (Pubitemid 20213610)
5. Cooney TP, Thurlbeck WM (1982) Pulmonary hypoplasia in Down's syndrome. N Engl J Med 307:1170-1173 (Pubitemid 12037976)
6. Cua CL, Cooke G, Taylor M, Hayes J, Waldon L, Lipowski P, Kossman B, Nash PL (2006) Endothelial nitric oxide synthase polymorphisms associated with abnormal nitric oxide production are not over-represented in children with Down syndrome. Congenit Heart Dis 1:169-174 (Pubitemid 44102902)
7. Cua CL, Blankenship A, North AL, Hayes J, Nelin LD (2007) Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates. Pediatr Cardiol 28:250-254 (Pubitemid 46976641)
8. Dimitroulas T, Giannakoulas G, Sfetsios T, Karvounis H, Dimitroula H, Koliakos G, Settas L (2008) Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension. Rheumatology (Oxford) 47:1682-1685
9. Durante W, Johnson FK, Johnson RA (2007) Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 34:906-911 (Pubitemid 47083958)
10. Fukushima H, Kosaki K, Sato R, Yagihashi T, Gatayama R, Kodo K, Hayashi T, Nakazawa M, Tsuchihashi T, Maeda J, Kojima Y, Yamagishi H, Takahashi T (2010) Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: an imbalance in biosynthesis of thromboxane A(2) and prostacyclin. Am J Med Genet A 152A(8):1919-1924
11. Girard C, Fargnoli JM, Godin-Ribuot D, Dutheil V, Maitrasse B, Girardet P, Arvieux CC (1996) Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension. J Heart Lung Transplant 15:700-708 (Pubitemid 26268889)
12. Holm T, Aukrust P, Aagaard E, Ueland T, Haugstad TS, Kjekshus J, Simonsen S, Froland SS, Gullestad L, Andreassen AK (2002) Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: different patterns in heart transplant recipients and individuals with essential hypertension. Transplantation 74:1395-1400 (Pubitemid 35379544)
13. Jin Y, Calvert TJ, Chen B, Chicoine LG, Joshi M, Bauer JA, Liu Y, Nelin LD (2010) Mice deficient in Mkp-1 develop more severe pulmonary hypertension and greater lung protein levels of arginase in response to chronic hypoxia. Am J Physiol Heart Circ Physiol 298:H1518-1528
14. Kielstein JT, Bode-Boger SM, Hesse G, Martens-Lobenhoffer J, Takacs A, Fliser D, Hoeper MM (2005) Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol 25:1414-1418 (Pubitemid 40923361)
15. Komai H, Naito Y, Aimi Y, Kimura H (2001) Nitric oxide synthase expression in lungs of pulmonary hypertensive patients with heart disease. Cardiovasc Pathol 10:29-32 (Pubitemid 32409987)
16. Levine OR, Simpser M (1982) Alveolar hypoventilation and cor pulmonale associated with chronic airway obstruction in infants with Down syndrome. Clin Pediatr (Phila) 21:25-29
17. Mallamaci F, Tripepi G, Cutrupi S, Malatino LS, Zoccali C (2005) Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int 67:2330-2337 (Pubitemid 41623394)
18. Matsuguma K, Ueda S, Yamagishi S, Matsumoto Y, Kaneyuki U, Shibata R, Fujimura T, Matsuoka H, Kimoto M, Kato S, Imaizumi T, Okuda S (2006) Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease. J Am Soc Nephrol 17:2176-2183 (Pubitemid 44141907)
19. McCaffrey MJ, Bose CL, Reiter PD, Stiles AD (1995) Effect of Larginine infusion on infants with persistent pulmonary hypertension of the newborn. Biol Neonate 67:240-243
20. McCormack D (1990) Endothelium-derived relaxing factors and the human pulmonary circulation. Lung 168(Suppl):35-42
21. Millatt LJ, Whitley GS, Li D, Leiper JM, Siragy HM, Carey RM, Johns RA (2003) Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension. Circulation 108:1493-1498 (Pubitemid 37176457)
22. Morris CR, Poljakovic M, Lavrisha L, Machado L, Kuypers FA, Morris SM Jr (2004) Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med 170:148-153 (Pubitemid 38925160)
23. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM Jr, Gladwin MT (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 294:81-90 (Pubitemid 41002842)
24. Nagaya N, Uematsu M, Oya H, Sato N, Sakamaki F, Kyotani S, Ueno K, Nakanishi N, Yamagishi M, Miyatake K (2001) Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. Am J Respir Crit Care Med 163:887-891 (Pubitemid 32275859)
25. Pearson DL, Dawling S, Walsh WF, Haines JL, Christman BW, Bazyk A, Scott N, Summar ML (2001) Neonatal pulmonary hypertension - urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N Engl J Med 344:1832-1838
26. Pullamsetti S, Kiss L, Ghofrani HA, Voswinckel R, Haredza P, Klepetko W, Aigner C, Fink L, Muyal JP, Weissmann N, Grimminger F, Seeger W, Schermuly RT (2005) Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension. FASEB J 19:1175-1177 (Pubitemid 40946456)
27. Skoro-Sajer N, Mittermayer F, Panzenboeck A, Bonderman D, Sadushi R, Hitsch R, Jakowitsch J, Klepetko W, Kneussl MP, Wolzt M, Lang IM (2007) Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 176:1154-1160 (Pubitemid 350223762)
28. Suzuki K, Yamaki S, Mimori S, Murakami Y, Mori K, Takahashi Y, Kikuchi T (2000) Pulmonary vascular disease in Down's syndrome with complete atrioventricular septal defect. Am J Cardiol 86:434-437 (Pubitemid 30628611)
29. Tang WH, Wang Z, Cho L, Brennan DM, Hazen SL (2009) Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. J Am Coll Cardiol 53:2061-2067
30. Weijerman ME, van Furth AM, van der Mooren MD, van Weissenbruch MM, Rammeloo L, Broers CJ, Gemke RJ (2010) Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr 169(10):1195-1199
31. Yamaki S, Yasui H, Kado H, Yonenaga K, Nakamura Y, Kikuchi T, Ajiki H, Tsunemoto M, Mohri H (1993) Pulmonary vascular disease and operative indications in complete atrioventricular canal defect in early infancy. J Thorac Cardiovasc Surg 106:398-405 (Pubitemid 23277608)